|
Daniel Soland has served as Vice President Chief Commercial Officer of ViroPharma since November 2006. He joined ViroPharma from his previous post as President of Chiron Vaccines. At Chiron Soland was most recently responsible for managing the vaccine division to annual sales of $1 billion. Prior to Chiron he was the president and chief executive officer of Epigenesis Pharmaceuticals a privately held biopharmaceutical company engaged in developing drugs for use in asthma COPD and allergic rhinitis. Prior to that Mr. Soland spent nine years with GlaxoSmithKline as the vice president and director of worldwide marketing operations and five years as their vice president and director of the U.S. vaccines business unit. Mr. Soland holds a Bachelor of Science degree in pharmacy from the University of Iowa in Iowa City IA. | 